Brent Douty
Wilmington University(US)Incyte (United States)(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Protein Tyrosine Phosphatases, PI3K/AKT/mTOR signaling in cancer, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Biochemical and Molecular Research
Most-Cited Works
- → INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology(2017)291 cited
- → Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model(2009)216 cited
- → Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics(2005)101 cited
- → Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor(1993)96 cited
- → The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist.(1994)89 cited
- → Structural Basis for Inhibition of Protein-tyrosine Phosphatase 1B by Isothiazolidinone Heterocyclic Phosphonate Mimetics(2006)83 cited
- → Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B(2006)61 cited
- → Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines(2007)58 cited
- → Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy(2020)50 cited
- → INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)(2019)48 cited